Rifabutin appears to be a promising agent for combination treatment of AIDS-related toxoplasma encephalitis

Research output: Contribution to journal › Comment/Letter to the editor › Academic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{82909b98499f490e962965a99e716512,

title = "Rifabutin appears to be a promising agent for combination treatment of AIDS-related toxoplasma encephalitis",

author = "D. Sch{\"u}rmann and Grobusch, \{M. P.\} and B. Ruf",

year = "1998",

doi = "10.1016/S0163-4453(98)95035-6",

language = "English",

volume = "36",

pages = "352--353",

journal = "Journal of infection",

issn = "0163-4453",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Rifabutin appears to be a promising agent for combination treatment of AIDS-related toxoplasma encephalitis

AU - Schürmann, D.

AU - Grobusch, M. P.

AU - Ruf, B.

PY - 1998

Y1 - 1998

U2 - 10.1016/S0163-4453(98)95035-6

DO - 10.1016/S0163-4453(98)95035-6

M3 - Comment/Letter to the editor

C2 - 9661961

SN - 0163-4453

VL - 36

SP - 352

EP - 353

JO - Journal of infection

JF - Journal of infection

IS - 3

ER -